Elanco Animal Health Incorporated (ELAN Quick QuoteELAN - Free Report) reported $1.18 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 12%. EPS of $0.30 for the same period compares to $0.18 a year ago.

The reported revenue represents a surprise of +3.23% over the Zacks Consensus Estimate of $1.15 billion. With the consensus EPS estimate being $0.24, the EPS surprise was +25.00%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Elanco Animal Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Total Pet Health

  : $579 million versus $593.58 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +11.8% change.

• Revenue- Total Contract Manufacturing

  : $11 million versus the four-analyst average estimate of $13.44 million. The reported number represents a year-over-year change of -8.3%.

• Revenue- Total Farm Animal

  : $594 million compared to the $548.11 million average estimate based on four analysts. The reported number represents a change of +12.7% year over year.

View all Key Company Metrics for Elanco Animal Health here>>>

Shares of Elanco Animal Health have returned -6.8% over the past month versus the Zacks S&P 500 composite's -6.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.